Genomic Valley Biotech Limited (BOM:539206)
India · Delayed Price · Currency is INR 27.34
-0.21 (-0.76%)
At close: Dec 3, 2025
Genomic Valley Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 6.64 | 8.44 | 1.65 | 27.23 | 0.71 | 2.08 | Upgrade | |
Revenue Growth (YoY) | 66.18% | 411.25% | -93.94% | 3758.23% | -66.09% | -75.42% | Upgrade |
Cost of Revenue | 2.01 | 2.01 | 0 | 15.86 | 0.02 | 1.3 | Upgrade |
Gross Profit | 4.62 | 6.43 | 1.65 | 11.37 | 0.68 | 0.78 | Upgrade |
Selling, General & Admin | 1.52 | 1.21 | 0.42 | 1.54 | 1.44 | 0.9 | Upgrade |
Other Operating Expenses | 1.1 | 0.82 | 1.06 | 1.04 | 2.44 | 1.07 | Upgrade |
Operating Expenses | 2.65 | 2.06 | 1.51 | 2.66 | 5.25 | 4.01 | Upgrade |
Operating Income | 1.97 | 4.37 | 0.14 | 8.71 | -4.56 | -3.23 | Upgrade |
Interest Expense | - | - | -0 | -0 | -0.43 | -1.79 | Upgrade |
Interest & Investment Income | - | - | - | 0.43 | 0.78 | 0 | Upgrade |
Other Non Operating Income (Expenses) | -0.03 | 0.04 | 0.02 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 1.94 | 4.41 | 0.15 | 9.13 | -4.21 | -5.02 | Upgrade |
Other Unusual Items | - | - | - | -2.64 | 4.19 | - | Upgrade |
Pretax Income | 1.94 | 4.41 | 0.15 | 6.49 | -0.02 | -5.02 | Upgrade |
Income Tax Expense | 0.85 | 0.85 | -0 | 0.01 | 0.08 | 0.57 | Upgrade |
Net Income | 1.09 | 3.56 | 0.15 | 6.48 | -0.09 | -5.59 | Upgrade |
Net Income to Common | 1.09 | 3.56 | 0.15 | 6.48 | -0.09 | -5.59 | Upgrade |
Net Income Growth | -54.68% | 2245.53% | -97.66% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Change (YoY) | 2.21% | 0.24% | -0.70% | -1.79% | 1.91% | 0.41% | Upgrade |
EPS (Basic) | 0.35 | 1.17 | 0.05 | 2.12 | -0.03 | -1.83 | Upgrade |
EPS (Diluted) | 0.35 | 1.17 | 0.05 | 2.12 | -0.03 | -1.83 | Upgrade |
EPS Growth | -55.67% | 2240.00% | -97.64% | - | - | - | Upgrade |
Free Cash Flow | -4.39 | 0.18 | -0.2 | -7.79 | -21.29 | -0.95 | Upgrade |
Free Cash Flow Per Share | -1.43 | 0.06 | -0.07 | -2.55 | -6.84 | -0.31 | Upgrade |
Gross Margin | 69.65% | 76.14% | 99.78% | 41.75% | 96.53% | 37.44% | Upgrade |
Operating Margin | 29.69% | 51.78% | 8.56% | 31.99% | -646.85% | -155.37% | Upgrade |
Profit Margin | 16.41% | 42.19% | 9.20% | 23.81% | -13.24% | -268.67% | Upgrade |
Free Cash Flow Margin | -66.23% | 2.14% | -12.16% | -28.60% | -3017.82% | -45.45% | Upgrade |
EBITDA | 2 | 4.4 | 0.15 | 8.79 | -3.72 | -1.34 | Upgrade |
EBITDA Margin | 30.16% | 52.08% | 9.22% | 32.28% | - | -64.44% | Upgrade |
D&A For EBITDA | 0.03 | 0.03 | 0.01 | 0.08 | 0.84 | 1.89 | Upgrade |
EBIT | 1.97 | 4.37 | 0.14 | 8.71 | -4.56 | -3.23 | Upgrade |
EBIT Margin | 29.69% | 51.78% | 8.56% | 31.99% | - | -155.37% | Upgrade |
Effective Tax Rate | 43.94% | 19.33% | - | 0.09% | - | - | Upgrade |
Revenue as Reported | 6.61 | 8.48 | 1.67 | 27.65 | 1.55 | 2.11 | Upgrade |
Advertising Expenses | - | - | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.